Clinical Trial Update: Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating docetaxel in combination with GVAX immunotherapy versus docetaxel with prednisone in prostate cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• GVAX Immunotherapy

Snippet

Sponsor: Cell Genesys | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED